Literature DB >> 953565

Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol.

E H McLaren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 953565      PMCID： PMC1687946          DOI： 10.1136/bmj.2.6030.283-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  Paradoxical rise in blood pressure during propranolol treatment.

Authors:  I Blum; A Atsmon; M Steiner; H Wysenbeek
Journal:  Br Med J       Date:  1975-12-13

2.  Physiological and pharmacological interactions of antihypertensive drugs.

Authors:  C T Dollery
Journal:  Proc R Soc Med       Date:  1965-11
  2 in total
  6 in total

1.  Hazards of phenylephrine topical medication in persons taking propranolol.

Authors:  E Cass; D Kadar; H A Stein
Journal:  Can Med Assoc J       Date:  1979-05-19       Impact factor: 8.262

2.  A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies.

Authors:  S H Thomas; K L Clark; R Allen; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

3.  Treatment of seasonal and perennial rhinitis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

Review 4.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 5.  Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Authors:  Y W Lam; A M Shepherd
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 6.  Beta-blocker therapy and the risk of anaphylaxis.

Authors:  J H Toogood
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.